Literature DB >> 14577060

Drug therapy in the elderly.

Rudolf E Noble1.   

Abstract

This review examines altered drug responses during aging. The incidence of diseases and disorders that require drug treatment rapidly increases with advancing age; elderly patients tend to receive more medications more often and are therefore at a correspondingly higher risk of experiencing adverse drug reactions and interactions. The cognitive decline that commonly accompanies aging can exacerbate this problem, with elderly individuals becoming confused and forgetful about their prescribed medications. Physiological responses to drugs depend on several factors, including the time course of drug absorption, distribution, metabolism, and elimination in the body (pharmacokinetics), and the actions of these drugs at the intracellular level (pharmacodynamics). As people age, the pathophysiologic processes of aging will influence all of these factors, including the time course of drug concentration in the body and target organ sensitivity. These age-related pharmacokinetic and pharmacodynamic effects must always be kept in mind by those responsible for the medical care of the elderly.

Entities:  

Mesh:

Year:  2003        PMID: 14577060     DOI: 10.1016/s0026-0495(03)00298-1

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study.

Authors:  Paulo Roque Obreli-Neto; Alessandro Nobili; André de Oliveira Baldoni; Camilo Molino Guidoni; Divaldo Pereira de Lyra Júnior; Diogo Pilger; Juliano Duzanski; Mauro Tettamanti; Joice Mara Cruciol-Souza; Walderez Penteado Gaeti; Roberto Kenji Nakamura Cuman
Journal:  Eur J Clin Pharmacol       Date:  2012-05-30       Impact factor: 2.953

2.  Real-Life Peak and Trough Dabigatran Plasma Measurements over Time in Hospitalized Geriatric Patients with Atrial Fibrillation.

Authors:  E Chaussade; O Hanon; C Boully; F Labourée; L Caillard; G Gerotziafas; J-S Vidal; I Elalamy
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

3.  Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.

Authors:  Jon Brännström; Katarina Hamberg; Lena Molander; Hugo Lövheim; Yngve Gustafson
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

4.  Pharmacokinetic and pharmacodynamic aspects of oral moxifloxacin 400 mg/day in elderly patients with acute exacerbation of chronic bronchitis.

Authors:  Federico Pea; Federica Pavan; Emilio Lugatti; Flavio Dolcet; Giovanni Talmassons; Maria Consuelo Screm; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 5.  Pharmacokinetic considerations relating to tacrolimus dosing in the elderly.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Immunosuppressive therapy in older cardiac transplant patients.

Authors:  Arezu Zejnab Aliabadi; Andreas Oliver Zuckermann; Michael Grimm
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 7.  Oral anticoagulants in older adults with atrial fibrillation.

Authors:  Gwen M Bernacki; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

8.  Pharmacokinetics and pharmacodynamics of the direct oral thrombin inhibitor dabigatran in healthy elderly subjects.

Authors:  Joachim Stangier; Hildegard Stähle; Karin Rathgen; Reinhold Fuhr
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: a randomised controlled study.

Authors:  Veronica Milos; Eva Rekman; Åsa Bondesson; Tommy Eriksson; Ulf Jakobsson; Tommy Westerlund; Patrik Midlöv
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

10.  Adverse drug reactions related hospital admissions in persons aged 60 years and over, The Netherlands, 1981-2007: less rapid increase, different drugs.

Authors:  Klaas A Hartholt; Nathalie van der Velde; Caspar W N Looman; Martien J M Panneman; Ed F van Beeck; Peter Patka; Tischa J M van der Cammen
Journal:  PLoS One       Date:  2010-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.